Prothena Corp. Plc (PRTA)
8.16
-0.07
(-0.85%)
USD |
NASDAQ |
Nov 13, 16:00
8.155
0.00 (0.00%)
Pre-Market: 19:59
Prothena Net Income (Quarterly) : -16.51M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -16.51M |
| June 30, 2026 | -18.58M |
| March 31, 2026 | 32.72M |
| December 31, 2025 | -21.59M |
| September 30, 2025 | -36.54M |
| June 30, 2025 | -125.77M |
| March 31, 2025 | -60.20M |
| December 31, 2024 | -57.96M |
| September 30, 2024 | -59.00M |
| June 30, 2024 | 66.89M |
| March 31, 2024 | -72.24M |
| December 31, 2023 | -67.48M |
| September 30, 2023 | 21.91M |
| June 30, 2023 | -54.60M |
| March 31, 2023 | -46.86M |
| December 31, 2022 | 6.349M |
| September 30, 2022 | -45.76M |
| June 30, 2022 | -41.24M |
| March 31, 2022 | -36.29M |
| December 31, 2021 | -33.18M |
| September 30, 2021 | 109.25M |
| June 30, 2021 | 27.64M |
| March 31, 2021 | -36.74M |
| December 31, 2020 | -30.72M |
| September 30, 2020 | -30.58M |
| Date | Value |
|---|---|
| June 30, 2020 | -26.28M |
| March 31, 2020 | -23.57M |
| December 31, 2019 | -21.55M |
| September 30, 2019 | -19.45M |
| June 30, 2019 | -15.81M |
| March 31, 2019 | -20.86M |
| December 31, 2018 | -22.46M |
| September 30, 2018 | -24.56M |
| June 30, 2018 | -59.88M |
| March 31, 2018 | -48.74M |
| December 31, 2017 | -47.76M |
| September 30, 2017 | -52.39M |
| June 30, 2017 | -17.70M |
| March 31, 2017 | -35.38M |
| December 31, 2016 | -48.90M |
| September 30, 2016 | -43.24M |
| June 30, 2016 | -40.44M |
| March 31, 2016 | -27.52M |
| December 31, 2015 | -24.16M |
| September 30, 2015 | -22.98M |
| June 30, 2015 | -18.28M |
| March 31, 2015 | -15.20M |
| December 31, 2014 | -13.11M |
| September 30, 2014 | -13.18M |
| June 30, 2014 | 1.29M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Alkermes Plc | 16.29M |
| Amarin Corp. Plc | 0.2449M |
| Agenus, Inc. | 1.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | -0.311M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.62M |
| Total Expenses (Quarterly) | 17.13M |
| EPS Diluted (Quarterly) | -0.321 |
| Enterprise Value | 153.83M |
| Gross Profit Margin (Quarterly) | -50.00% |
| Profit Margin (Quarterly) | -2.66K% |
| Earnings Yield | -5.81% |
| Normalized Earnings Yield | -6.490 |